Collectively, these data unravel the undetermined oncogenic function of TRIM8 in HCC and establish TRIM8 as a novel diagnostic and prognostic biomarker and therapeutic target for HCC patients. The gene discussed is TRIM8; the disease is hepatocellular carcinoma.